Insights
Stock market volatility can be an opportunity for investors in long term
Mark Riggall, 25 Jan 2022
Financial markets have started the year on a weak note, what’s behind the moves and how are we seeing things?…
Stock Story: Neuren Pharmaceuticals
Kate Power, 12 Jan 2022
A promising new drug therapy for those with Rett Syndrome In December, Neuren Pharmaceuticals and its partner Acadia Pharmaceuticals announced…
Month in a Minute: December ’21
Mark Riggall, 12 Jan 2022
Portfolio Manager Mark Riggall discusses the month’s key highlights in 60 seconds. A wider perspective Fund returns in December…
Monday Market Highlights: 20th December 2021
Roland Houghton, 20 Dec 2021
This week on Monday Market Highlights, Investment Analyst Roland Houghton covers the Federal Reserve committee meeting, UK inflation data, Australian…
Corporate Demergers
Alexander Whight, 14 Dec 2021
Profiting from Management Spin? Opportunities presented by corporate demergers Breaking up is hard to do. But that is the journey…
Monday Market Highlights: 13th December 2021
Roland Houghton, 13 Dec 2021
This week on Monday Market Highlights, Investment Analyst Roland Houghton covers US inflation, the US labour market, Consortium’s Sydney…
Omicron the new Delta?
Jason Kururangi, 07 Dec 2021
Omicron the new Delta? Whilst we don’t know where the exact economic outcomes will end up being from Omicron, we…
Month in a Minute: November ’21
Mark Riggall, 06 Dec 2021
Portfolio Manager Mark Riggall discusses the month’s key highlights in 60 seconds. Omicron the headline, interest rates remain the…